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DObjective: To compare the outcomes of right minithoracotomy (RT) versus ministernotomy (MS) in patients
undergoing minimally invasive aortic valve replacement (AVR).
Methods: From January 2005 to December 2011, 406 patients underwent minimally invasive AVR, of whom
251 patients were in the RT group and 155 were in the MS group.
Results: The overall in-hospital mortality was 1.2% with no difference between the 2 groups (1.2% in RT vs
1.3% in MS). Patients undergoing minimally invasive AVR using RT had a lower incidence of postoperative
atrial fibrillation (19.5% vs 34.2%, P¼ .01), shorter ventilation time (median, 7 vs 8 hours; interquartile range,
5-9 vs 6-12 hours, P ¼ .003), intensive care unit stay (median 1 vs 1 day; interquartile range, 1-1 vs 1-2 days;
P¼ .001), and hospital stay (median, 5 vs 6 days; interquartile range, 5-6 vs 5-8 days; P¼ .0001). No difference
was found in terms of cardiopulmonary time, crossclamping time, postoperative stroke, re-exploration for
bleeding, or blood transfusion.
Conclusions: Minimally invasive AVR using RT was associated with lower postoperative morbidities and a
shorter hospital stay than MS. (J Thorac Cardiovasc Surg 2014;148:133-7)Minimally invasive aortic valve replacement (AVR) refers to
a small chest wall incision that does not include the conven-
tional full sternotomy and, in recent years, has become an
alternative to the standard approach.1,2 Minimally invasive
AVR has been shown to reduce postoperative mortality
and morbidity while allowing a faster recovery, fewer
blood transfusions, less pain, a shorter hospital stay, and
better esthetic results.3-5 The most common minimally
invasive technique for AVR has been the ministernotomy
(MS) approach, and the outcomes reported from several
meta-analyses have focused mainly on this procedure.3,4
Few studies have evaluated the potential advantages of
minimally invasive AVR through the anterior right
minithoracotomy (RT) approach. Previously, we described
our initial experience with RT, showing excellent early
and midterm results for mortality, morbidity, and
patient satisfaction.6 Furthermore, compared with standard
sternotomy, RT was associated with a lower incidence of
postoperative atrial fibrillation (AF) and blood transfusion
and shorter ventilation time and hospital length of stay.7
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The Journal of Thoracic and Caoutcomes between the RT and MS approach in patients un-
dergoing isolated AVR. Therefore, the aim of our study
was to compare the early outcomes and midterm
survival of RT versus MS in patients undergoing minimally
invasive AVR.METHODS
This was a retrospective, observational, cohort study of prospectively
collected data from 856 consecutive patients who had undergone isolated
AVR through either a minimally invasive or full sternotomy approach at
our institution from January 2005 to December 2011. The local ethical
committee approved the study, and the requirement for individual patient
consent was waived. The data collection form was entered in a local
database and included 3 sections completed consecutively by the cardiac
surgeons, anesthetists, and perfusionists involved in the patients’ care.
The exclusion criteria were full sternotomy in 382, active endocarditis
in 24, a critical preoperative state in 9, and a transcatheter aortic valve
implantation approach in 35.
The final sample contained detailed clinical information for 406 pa-
tients, of whom, 251 (61.8%) had undergoneAVRusingRT. The remaining
155 patients (38.2%) had undergone anMS approach. In-hospital mortality
was defined as any death occurring during the same hospital admission for
surgery. AF was defined by the documentation of AF of any duration at any
point in the postoperative period on a rhythm strip or 12-lead electrocardio-
gram. Finally, postoperative stroke was diagnosed if evidence was found of
a new neurologic deficit with a morphologic substrate confirmed by
computed tomography or nuclear magnetic resonance imaging. All patients
were seen 8 to 12 weeks postoperatively and, thereafter, were contacted for
follow-up data. The median follow-up period was 35 months (interquartile
range, 22-52), and the follow-up data were 97% complete.
Preoperative Planning and Surgical Procedure
The preoperative planning and surgical techniques have been
previously described.6,7 In brief, all patients scheduled for AVRrdiovascular Surgery c Volume 148, Number 1 133
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Dunderwent 64-slice computed tomography (Toshiba Aquilon; Toshiba
Medical System, Tokyo, Japan) without contrast enhancement to
evaluate the anatomic relationship among the intercostal spaces,
ascending aorta, and aortic valve. The exclusion criteria for the RT
approach were previous cardiac surgery or right chest surgery, a history
of right pleuritis, and the presence of an ascending aorta aneurysm.
Furthermore, patients were considered suitable for RT only if the
following criteria were met: (1) at the level of the main pulmonary
artery, the ascending aorta was rightward (more than one half located
on the right in respect to the right sternal border); and (2) the distance
from the ascending aorta to the sternum did not exceed 10 cm. If these
criteria were not reached, MS was considered as the alternative
approach for minimally invasive AVR (Figure 1).
Minimally invasive AVR using RTwas performed through a 5- to 7-cm
skin incision placed at the level of the second or third intercostal
space without rib resection. In the MS group, MS was achieved through
a 6- to 8-cm midline, vertical skin incision, creating a V-shaped opening.
Specifically, MS was performed with a standard saw, starting at the level
of the sternal notch up to the level of the second intercostal space.
Afterward, the sternotomy was continued into the right and left second
intercostal space (V-shaped) taking care to avoid injuring the right internal
thoracic artery and the mediastinal structures.8 In both approaches, direct
aortic cannulation was performed using low-profile cannulas such as
Easyflow (Sorin, Sallugia, Italy) or Straightshot (Edwards LifeSciences,
Irvine, Calif). Venous drainage was achieved with a variety of
percutaneous venous cannulas such as BioMedicus multistages
(Medtronic, Minneapolis, Minn), Quickdraw (Edwards LifeSciences),
RAP (Sorin), or Smartcannula (Smartcannula, Lausanne, Switzerland)
inserted through the femoral vein into the right atrium. The correct posi-
tion was reached using the Seldinger technique with transesophageal
echocardiographic guidance. After vacuum-assisted cardiopulmonary
bypass (40 to 60 mm Hg) was established, a left ventricular vent
was placed through the right superior pulmonary vein, and the patients
were cooled to 34C. The ascending aorta was clamped with the Cygnet
crossclamp (Novare Surgical Systems, Cupertino, Calif) or with the
aortic Glauber clamp (Cardiomedical GmbH, Langenhagen, Germany;
distributed by Sorin), and antegrade cardioplegic solution was given
into the aortic root or selectively into the coronary ostia using warm blood
cardioplegia or cold crystalloid solution (Custodiol Koehler Chemie,
Alsbach-Haenlein, Germany). In all cases, the surgical field was flooded
with carbon dioxide at a flow of 0.5 L/min.
Statistical Analysis
Continuous data are presented as the mean  standard deviation or
median and interquartile range when the data were skewed. Categorical
data are expressed as percentages. The Kolmogorov-Smirnov test was
used to check for the normality of data in the 2 groups before additional
analysis. Differences between the 2 groups were compared using the
chi-square test for categorical variables and the t test or Wilcoxon rank
sum test, as appropriate, for continuous variables. Long-term survival
was evaluated using the Kaplan-Meier survival method, and the log-rank
test was used to compare the 2 groups. All reported P values are 2-sided.
All statistical analysis was performed with Statistical Package for Social
Sciences, version 15.0 (SPSS, Chicago, Ill).134 The Journal of Thoracic and Cardiovascular SurgRESULTS
The baseline characteristics are reported in Table 1. The
RT group had a lower prevalence of female gender. No other
differences were found in terms of age, cardiovascular risk
factors, and aortic valve disease. The patients in the
RT group had slightly longer cardiopulmonary bypass
(124.9  38.2 vs 122.2  36.7 minutes; P ¼ .48) and
crossclamp (89.7  28.3 vs 84.3  25.3 minutes;
P ¼ .07) times. Four RT patients (1.6%) required intraope-
rative conversion to sternotomy for paravalvular leak
(n ¼ 1), developed severe pleural adhesions (n ¼ 2), or
experienced bleeding from the aortic root (n ¼ 1). In the
MS group, 3 patients (1.9%) required conversion to
sternotomy for uncontrolled bleeding (Table 2). The overall
in-hospital mortality was 1.2%, with no difference between
the 2 groups (1.2% in the RT vs 1.3% in the MS group;
Table 3). Patients undergoing minimally invasive AVR
using RT had a lower incidence of postoperative AF
(19.5% vs 34.2%, P ¼ .01), shorter ventilation time
(median, 7 hours; interquartile range [IR], 5-9 hours; vs
median, 8 hours; IR, 6-12 hours; P ¼ .003), intensive
care unit stay (median, 1 day; IR, 1-1; vs median, 1 day;
IR, 1-2; P ¼ .001) and ward stay (median, 5 days; IR,
5-6; vs median, 6 days; IR, 5-8; P ¼ .0001). No difference
was found in terms of postoperative stroke, re-exploration
for bleeding, or blood transfusion. The survival in patients
undergoing RT or MS at 1 and 5 years was 97% and 86%
and 94% and 80%, respectively (P ¼ .1; Figure 2).
DISCUSSION
We have demonstrated that minimally invasive aortic
valve procedures using either RT or MS can be
performed safely and is associated with a low incidence
of postoperative mortality and postoperative complications.
Furthermore, patients undergoing RT for minimally
invasive AVR had a lower incidence of postoperative AF,
shorter ventilation time, and shorter hospital stay compared
with those in the MS group. The first minimally invasive
AVR approach was performed through a 10-cm right
parasternal approach in 1996 at the Cleveland Clinic
Foundation.9 This technique consisted of removing the
second, third, and fourth costal cartilages, sacrificing the
right internal thoracic artery. However, the major limitation
of the parasternal procedure was related to a high incidence
of lung herniation, that it was cosmetically disfiguring, and
that it often required a second operation to repair the
defect.10 Consequently, the invasiveness of this technique
led other surgeons to abandon the parasternal approach in
favor of the MS technique.11 Compared with conventional
standard sternotomy, MS has been shown to reduce
postoperative complications and result in a shorter length
of stay and, thus, a lower use of hospital resources.3-5,12-16
In a meta-analysis of 4586 patients, Brown and colleagues3
found that the ventilation time, intensive care unit stay, andery c July 2014
FIGURE 1. Anatomic and radiologic aspects of patients undergoing either, Left, right thoracotomy or, Right, ministernotomy approach.
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In addition, a slight difference was found in terms of blood
loss within 24 hours in favor of the partial upper sternotomy
group.3 Murtuza and colleagues4 confirmed similar results
in an additional meta-analysis, analyzing 4891 patients
undergoing any minimally invasive AVR approach.
Both reports suggested that patients undergoing any
minimally invasive procedure had an overall 28% to 29%
reduction in perioperative mortality. Despite these excellent
outcomes, previous prospective randomized studies have
reported controversial results. Some studies have shown
potential advantage in blood transfusion, early extubation,
and early hospital discharge, but others have failed to
show any theoretical advantages for minimally invasive
AVR.13-16 In addition, a meta-analysis of randomized
controlled trials demonstrated no difference in early
mortality, operative and ventilation times, hospital stay, or
postoperative AF, pain, or sternal complications.3,4
However, these studies were limited by small sample
sizes (average, 40 patients per study) and therefore wereTABLE 1. Baseline characteristics
Characteristic RT (n ¼ 251) MS (n ¼ 155) P value
Age (y) 67.2  12.8 68.5  11.5 .27
Female gender 86 (34.3) 74 (47.7) .09
COPD 35 (14) 24 (15.5) .75
Hypertension 169 (67.3) 116 (74.8) .13
Diabetes mellitus 48 (19) 35 (22.6) .47
NYHA class III-IV 65 (25.9) 41 (26.5) .9
LVEF (%) 56.7  8.5 56.2  6.7 .68
LVEF<35% 7 (2.8) 8 (5.2) .34
Extracardiac vasculopathy 25 (10) 22 (14.2) .26
Pulmonary hypertension 25 (10) 22 (14.2) .26
Aortic valve disease .67
Aortic stenosis 130 (51.8) 87 (56.1)
Aortic regurgitation 51 (20.3) 30 (19.3)
Mixed 70 (27.9) 38 (24.5)
EuroSCORE 5.1 (2.7-9.7) 5.5 (3.2-9) .45
Data presented as mean  standard deviation, n (%), or median (range).
RT, Right minithoracotomy; MS, ministernotomy; COPD, chronic obstructive
pulmonary disease; NYHA, New York Heart Association; LVEF, left ventricular
ejection fraction.
The Journal of Thoracic and Caunpowered to evaluate the potential benefit of minimally
invasive AVR. A few studies have reported the
outcomes associated with the RT approach.6,12,17 In a
propensity-matched study, we demonstrated that patients
undergoing RT had a lower incidence of postoperative AF
and blood transfusions, a shorter ventilation time, and
shorter postoperative length of stay compared with those
undergoing standard sternotomy.7 Similar results were
reached in the present study. Specifically, the patients
undergoing RT had a 15% absolute reduction in postopera-
tive AF, shorter ventilation, and intensive care unit stay and
1 day less in terms of the postoperative length of hospital
stay. The lower incidence of AF and shorter mechanical
ventilation time might have been related to the less trauma
induced by the RT approach. The preservation of the
sternum would reduce the postoperative pain, improving
the respiratory function, and the smaller pericardial incision
and the absence of manipulation of the right atrium for
venous drainage would reduce the inflammation response,
triggering less AF.2,18 Furthermore, other potential risk
factors for postoperative AF could be the use of different
cardioplegia solutions (mostly Custodiol in the RT group)
and the greater distance between the aorta and sternum, as
an index of pulmonary disease, in patients undergoing
MS. Few studies have shown a potential advantage of
minimally invasive AVR in the setting of postoperative
AF. Although not statistically significant, De Smeth and
colleagues18 found a 10% reduction in postoperative AF.
In contrast, Asher and colleagues19 demonstrated a lower
incidence of postoperative AF associated with minimallyTABLE 2. Intraoperative characteristics
Variable RT (n ¼ 251) MS (n ¼ 155) P value
Ascending aortic–femoral
venous cannulation
227 (90.4) 154 (99.4) .01
CPB time (min) 124.9  38.2 122.2  36.7 .48
Crossclamp (min) 89.7  28.3 84.3  25.3 .07
Conversion to sternotomy 4 (1.6) 3 (1.9) 1
Data presented as n (%) or mean  standard deviation. RT, Right minithoracotomy;
MS, ministernotomy; CPB, cardiopulmonary bypass.
rdiovascular Surgery c Volume 148, Number 1 135
TABLE 3. Outcomes
Variable RT (n ¼ 251) MS (n ¼ 155) P value
Mortality 3 (1.2) 2 (1.3) 1
Stroke 3 (1.2) 2 (1.3) 1
Re-exploration for bleeding 12 (4.8) 5 (3.2) .61
Blood transfusion 51 (20.3) 40 (25.8) .24
New-onset postoperative AF 49 (19.5) 53 (34.2) .01
Ventilation time (h) 7 (5-9) 8 (6-12) .003
ICU stay (d) 1 (1-1) 1 (1-2) .001
Ward stay (d) 5 (5-6) 6 (5-8) .0001
Data presented as n (%) or median (range). RT, Right minithoracotomy;MS, minister-
notomy; AF, atrial fibrillation; ICU, intensive care unit.
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patients undergoing MS, and the present study is the first
to compare the outcomes after 2 different minimally
invasive AVR approaches. The rate of blood transfusion
was low for both procedures without any difference,
confirming that less blood loss and transfusion requirements
are the main advantages of minimally invasive surgery.3,4
Finally, because of these results, the less surgical trauma
induced by RT might translate to a shorter postoperative
hospital stay and the use of fewer rehabilitation resources.
Although we showed excellent outcomes, many criticisms
remain regarding minimally invasive AVR. First, many
surgeons prefer the term ‘‘minimal access’’ to ‘‘minimally
invasive.’’ The Society of Thoracic Surgeons database has
defined minimally invasive cardiac surgery as any
procedure not performed with a full sternotomy and
cardiopulmonary support; however, according to a new
scientific statement from the American Heart Association,
minimally invasive refers to a small chest wall incision
that does not include a full sternotomy.1,20 Second,
minimally invasive is more related to the cosmeticsFIGURE 2. Kaplan-Meier curve comparing survival between patients
undergoing right thoracotomy (RT) versus ministernotomy (MS) (log-rank
test, P ¼ .1).
136 The Journal of Thoracic and Cardiovascular Surgresults than better clinical outcomes, because randomized
trials have reported conflicting results. However, these
randomized controlled trials were old and unpowered. In
addition, the opportunity to design a randomized trial
with an appropriate sample size would not be easy
because minimally invasive AVR has shown excellent
results, and patients now demand less-invasive procedures.
Another criticism regards the morbidities related to the
femoral arterial cannulation in terms of pseudoaneurysm,
wound dehiscence, and neurologic events.4 To avoid this
complication, we have usually preferred direct aortic
cannulation, which is more physiologic than the retrograde
perfusion. We have recently demonstrated that antegrade
perfusion is associated with an important reduction in
neurologic events.21 Finally, the longer cardiopulmonary
and crossclamp times associated with the minimally
invasive approach might be a cause of postoperative
morbidities. We have confirmed that the operative times
associated with minimally invasive AVR are longer than
those with sternotomy7; however, with the introduction of
sutureless valves, we have obtained a 50% reduction in
the cardiopulmonary bypass and crossclamp times. Thus,
we believe that the RT approach using sutureless valves
might be the ‘‘real alternative’’ to the transcatheter aortic
valve implantation procedures in high-risk patients. It has
been shown that transcatheter aortic valve implantation
procedures are associated with a greater incidence of
vascular complications, strokes, and paravalvular leakage
and higher costs.22,23 In contrast, sutureless valve have
shown excellent early clinical results and a lower
incidence of paravalvular leakage.24,25 Therefore, our
belief is that several patients considered candidates for a
transcatheter aortic valve implantation procedure might be
shifted to an RT approach with sutureless valves.
However, prospective randomized trials are required to
confirm these data.
Our study had several limitations. It was based on the
retrospective analysis of our institutional, observational,
prospectively collected database, and we were unable to
account for the influence of any residual unmeasured
factors that could affect the adverse outcomes.
Despite the presence of many potential biases, the
patients’ baseline characteristics were similar in both
groups. This was probably related to the similar selection
of patients undergoing minimally invasive AVR, especially
at the beginning of our surgeons’ experience.
Although, we found better outcomes associated with RT
approach, we recognize that these 2 minimally invasive
approaches are not directly comparable. The RT and MS
approaches were chosen according to the anatomic position
of the ascending aorta after computed tomographic
evaluation. Therefore, a prospective randomized trial is
required to compare these 2 less-invasive techniques
only in the presence of patients with a rightward aorta.ery c July 2014
Miceli et al Acquired Cardiovascular DiseaseFinally, because RT has become the first approach for AVR
in recent years, a potential bias might have been the mind
set of the postoperative team who might treat patients
undergoing these procedures differently.CONCLUSIONS
Minimally invasive AVR is a safe approach associated
with low operative mortality and morbidity. However,
patients undergoing the RT approach had better outcomes
in terms of postoperative AF, ventilation time, and post-
operative hospital stay. Prospective randomized trials are
required to confirm our data.A
C
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